Treatment of resting zone chondrocytes with transforming growth factor-β1 induces differentiation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25-(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3

被引:17
|
作者
Schwartz, Z
Sylvia, VL
Liu, Y
Dean, DD
Boyan, BD
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Orthopaed, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Periodont, San Antonio, TX 78284 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA
[4] Hebrew Univ Jerusalem, Hadassah Fac Dent Med, Dept Periodont, Jerusalem, Israel
关键词
chondrocytes; differentiation; cartilage; transforming growth factor-beta; 1,25-dihydroxyvitamin D-3;
D O I
10.1016/S8756-3282(98)00132-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine if transforming growth factor-beta 1 (TGF-beta 1) can induce the differentiation of resting zone (RC) chondrocytes, confluent, fourth passage cultures of these cells were pretreated for 24, 36, 48, 72, and 120 h with TGF-beta 1. At the end of pretreatment, the media were replaced with new media containing 10(-10)-10(-8) mol/L 1,25-(OH)(2)D-3 and the cells incubated for an additional 24 h, This second treatment was chosen because prior studies had shown that only the more mature growth zone (GC) chondrocytes respond to this vitamin D-3 metabolite. The effect of TGF-beta pretreatment on cell maturation was assessed by measuring alkaline phosphatase (ALPase)-specific activity. In addition, changes in matrix protein synthesis were assessed by measuring collagen synthesis, as well as (SO4)-S-35 incorporation into proteoglycans. When RC cells were pretreated for 120 h with TGF-beta 1, treatment with 1,25-(OH)(2)D-3 caused a dose-dependent increase in ALPase-specific activity and collagen synthesis, with no effect on proteoglycan production. RC cells pretreated with 1,25-(OH)(2)D-3 responded like RC cells that had not received any pretreatment. RC cells normally respond to 24,25-(OH)(2)D-3; however, RC cultures pretreated for 120 h with TGP-beta 1 lost their responsiveness to 24,25-(OH)(2)D-3. These results indicate that TGF-beta 1 directly regulates the maturation of RC chondrocytes into GC chondrocytes and support the hypothesis that this growth factor may play a significant role in regulating chondrocyte maturation during endochondral ossification. (C) 1998 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 50 条
  • [31] PRODUCTION OF 24,25(OH)2D3 AND 1,25(OH)2D3 BY HUMAN FORESKIN KERATINOCYTES - REGULATION BY 1,25(OH)2D3
    NEMANIC, M
    BIKLE, D
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1178 - 1178
  • [32] EFFECTS OF 1,25-(OH)2VITAMIN-D3 (1,25-(OH)2D3) ON CIRCADIAN MINERAL PATTERNS IN HUMANS
    MARKOWITZ, ME
    ROSEN, JF
    MIZRUCHI, M
    CLINICAL RESEARCH, 1984, 32 (02): : A402 - A402
  • [33] COMPENSATORY RENAL GROWTH - MODULATION BY CALCIUM PTH AND 1,25-(OH)2D3
    JOBIN, JR
    BONJOUR, JP
    KIDNEY INTERNATIONAL, 1986, 29 (06) : 1124 - 1130
  • [34] 24,25(OH)2D3 ENHANCES THE CALCEMIC EFFECT OF 1,25(OH)2D3 - EVIDENCE FOR HYPOCALCIURIC ACTION OF 24,25(OH)2D3
    POPOVTZER, MM
    HAYEK, T
    WALD, H
    KIDNEY INTERNATIONAL, 1983, 23 (01) : 108 - 108
  • [35] Regulation of resting zone chondrocytes by 24,25-(OH)(2)D-3 is mediated by diacylglycerol and protein kinase C
    Helm, S
    Sylvia, V
    Kimbel, K
    Gomez, R
    Dean, DD
    Schwartz, Z
    Boyan, BD
    JOURNAL OF DENTAL RESEARCH, 1996, 75 : 2671 - 2671
  • [36] ACTION OF 1,25(OH)2D3 AND 24,25(OH)2D3 ON BONE - EVIDENCE FOR BIOLOGICAL-ACTIVITY OF 24,25(OH)2D3
    MALLUCHE, HH
    SHERMAN, D
    MEYER, W
    HENRY, H
    NORMAN, AW
    MASSRY, SG
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 828 - 828
  • [37] 24,25(OH)2D3 ENHANCES THE CALCEMIC EFFECT OF 1,25(OH)2D3
    WALD, H
    HAYEK, T
    POPOVTZER, MM
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1985, 180 (02): : 219 - 223
  • [38] EFFECT OF 1,25(OH)2D3 AND 24,25(OH)2D3 ON EXPERIMENTAL RICKETS
    KRAFT, D
    OFFERMANN, G
    STELDINGER, R
    GAWLIK, D
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1979, 26 (03): : 571 - 580
  • [39] Evidence for distinct membrane receptors for 1α,25-(OH)2D3 and 24R,25-(OH)2D3 in osteoblasts
    Boyan, BD
    Bonewald, LF
    Sylvia, VL
    Nemere, I
    Larsson, D
    Norman, AW
    Rosser, J
    Dean, DD
    Schwartz, Z
    STEROIDS, 2002, 67 (3-4) : 235 - 246
  • [40] 1,25(OH)2D3 RECEPTORS AND REGULATION OF 24,25-(OH)2D3 PRODUCTION IN CULTURED PIG-KIDNEY CELLS (LLC-PK1)
    COLSTON, K
    FELDMAN, D
    CALCIFIED TISSUE INTERNATIONAL, 1981, 33 (03) : 332 - 332